Summary
3H-labelled terguride was rapidly and completely absorbed in the rat after oral administration of up to 50 mglkg. In the rhesus monkey, absorption was prolonged. The bioavailability of terguride was 79% in the rat and 15% in the monkey. Plasma levels of the unchanged drug declined with a half-life of 50 min (rat) or 20 min (monkey). Tissue distribution as studied by autoradiography in pregnant rats showed highest concentrations of labelled compounds in the liver, the cervical gland and the kidney. Lower levels were found in the thymus, the spinal cord, the placenta and the heart muscle followed by the fetal tissue, the muscles and the brain. Radioactivity was excreted mainly in the faeces when administered to the rat and to a higher extent in the urine after treatment of rhesus monkeys.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wachtel H., Dorow R. (1983): Dual action on central dopamine function of transdihydro1isuride, 9, 10-dihydrogenated analogue of the ergot dopamine agonist lisuride. Life Sci., 32, 421–432.
Kehr W., Speckenbach W. (1978): Effect of lisuride and LSD on monoamine synthesis after axotonomy or reserpine treatment in rat brain. Naunyn Schmiedebergs Arch. Pharmacol., 301, 163–169.
Horowski R., Wendt H., Gräf K.-J. (1978): Prolactin-lowering effect of low doses of lisuride in man. Acta Endocrinol., 87, 234–240.
Auskova M., Rezabek K., Zikan V., Semonsky M. (1974): Laktationshemmende Wirlrung von N-(O-6-Methyl-8-isoergolin-1-yl)- N′, N′-diäthylhamstoff (VÜFB-6638). Experientia, 30, 393–394.
Krause W., Dorow R., Nieuweboer B., Hasan S.H. (1984): Pharmacokinetics and pharmacodynamics of the ergot derivative, transdihydrolisuride, in man. Eur. J. Clin. Pharmacol., 27, 335–339
Hümpel M., Toda T., Oshino N., Pommerenke G. (1981): The pharmacokinetics of lisuride hydrogen maleate in rat, rabbit and rhesus monkey. Eur. J. Drug Metab. Pharmacokin., 6, 207–219.
Hümpel M., Krause W., Hoyer G.-A., Wendt H., Pommerenke G. (1984): The pharmacokinetics and biotransfonnation of14C-li-suride hydrogen maleate in rhesus monkey and man. Eur. J. Drug Metab. Pharmacokin., 9, 347–357.
Hümpel M, Nieuweboer B., Hasan S.H., Wendt H. (1981): Radioimrnunoassay of plasma lisuride in man following intravenous and oral administration of lisuride hydrogen maleate; effect on plasma prolactin level. Eur. J. Clin. Pharmacol., 20, 47–51.
Bonelli J., Hitzenberger G., Krause W., Wendt H., Speck U. (1980): Pharmacokinetics and pharmacodynamics of mepindolol sulphate. Int. J. Clin. Pharmacol. Ther. Toxicol., 18, 169–176.
Ullberg S. (1954): Study on distribution and fate of35S-Iabelled benzylpenicillin in body. Acta Radiol., 118 (Suppl.), 1–110.
Hümpel M. (1986): personal communication
Hildebrand M., Hümpel M., Krause W., Täuber U. (1987): Pharmacokinetics of bromerguride, a novel dopamine-antagonistic ergot derivative, in rat and dog. Eur. J. Drug Metab. Pharmacokin., 12, 31–40.
Krause W., Hümpel M. (1988): Pharmacokinetics of proterguride in the rat and cynomolgus monkey. Xenobiotica, 18, 41–48.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krause, W., Hümpel, M. Pharmacokinetics of the dopamine partial agonist, terguride, in the rat and rhesus monkey. European Journal of Drug Metabolism and Pharmacokinetics 13, 185–194 (1988). https://doi.org/10.1007/BF03189938
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189938